Literature DB >> 9663531

Bi-directional cavopulmonary shunt associated with ventriculo and valvuloplasty in Ebstein's anomaly: benefits in high risk patients.

S Chauvaud1, J F Fuzellier, A Berrebi, P Lajos, J P Marino, S Mihaileanu, A Carpentier.   

Abstract

OBJECTIVE: The prognosis for surgical repair of Ebstein's anomaly depends on the tricuspid valve repair and on the right ventricular function. In order to decrease the preload of the compromised right ventricle, a bi-directional cavopulmonary shunt was added to the intracardiac repair.
METHODS: Among 113 patients operated on for Ebstein' s anomaly at our institution from 1980-1997, a cohort of 60 patients was selected for high risk for postoperative complications. Patients presented with one or more several criteria: massive tricuspid valve dysfunction, extended atrialized right ventricle, poor right ventricular contractility, or long standing atrial fibrillation. After prior informed consent, this cohort was divided into two groups. Both groups had similar preoperative clinical patterns: Group I (45 patients), surgical technique included longitudinal right ventricular plication and tricuspid valve valvuloplasty; Group II (15 patients), where the surgical technique was similar to Group I except a bi-directional cavopulmonary shunt was added at the end of the procedure.
RESULTS: Operative mortality was 24% (11/45) in Group I and 0% (0/15) in Group II (P < 0.05). The survival at 5 years was 66.1 +/- 14% in Group I and 80 +/- 16% in Group II (not significant). Reoperation rate was 11% (5/45) in Group I and 0% (0/15) in Group II. No deleterious effects of the bi-directional cavopulmonary shunts were observed clinically. Residual tricuspid valve insufficiency rate was 26% in both groups. However, patients with the bi-directional cavopulmonary shunt had a better tolerance and have not needed reoperations to date.
CONCLUSIONS: In high risk patients with Ebstein's anomaly, an associated bi-directional cavopulmonary shunt seems to offer several distinct advantages including decreased operative mortality and better tolerance of the residual tricuspid valve dysfunction.

Entities:  

Mesh:

Year:  1998        PMID: 9663531     DOI: 10.1016/s1010-7940(98)00057-8

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

1.  Modified Cone Reconstruction of the Tricuspid Valve for Ebstein Anomaly as Performed in Siberia.

Authors:  Evgeny V Krivoshchekov; Jaeger P Ackerman; Olga S Yanulevich; Alexander A Sokolov; Nadezhda V Ershova; Joseph A Dearani; Frank Cetta
Journal:  Tex Heart Inst J       Date:  2017-02-01

2.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome.

Authors:  Candice K Silversides; Marla Kiess; Luc Beauchesne; Timothy Bradley; Michael Connelly; Koichiro Niwa; Barbara Mulder; Gary Webb; Jack Colman; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

3.  Ebstein malformation of the tricuspid valve: current concepts in management and outcomes.

Authors:  Morgan L Brown; Joseph A Dearani
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-10

4.  Ebstein's anomaly of the tricuspid valve.

Authors:  Michelle Gurvitz; Karen Stout
Journal:  Curr Cardiol Rep       Date:  2007-07       Impact factor: 2.931

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.